{"id":"https://openalex.org/W2761941968","doi":"https://doi.org/10.1093/annonc/mdx373.045","title":"Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma","display_name":"Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2761941968","doi":"https://doi.org/10.1093/annonc/mdx373.045","mag":"2761941968"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdx373.045","doi":"https://doi.org/10.1093/annonc/mdx373.045","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx373.045","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)38311-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(20)38311-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091204991","display_name":"Marie Payton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Payton","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057809247","display_name":"Dawn E. Pinchasik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Pinchasik","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mehta","raw_affiliation_strings":["Hematology & Oncology, University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology & Oncology, University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029455802","display_name":"Sanjay Goel","orcid":"https://orcid.org/0000-0002-2798-7568","observed_orcids":["https://orcid.org/0000-0002-2798-7568"]},"institutions":[{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Goel","raw_affiliation_strings":["Department of Medicine, Montefiore Medical Center, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Montefiore Medical Center, Bronx, NY, USA","institution_ids":["https://openalex.org/I1335289525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013307217","display_name":"Jasmine M. Zain","orcid":"https://orcid.org/0009-0009-0753-1019","observed_orcids":["https://orcid.org/0009-0009-0753-1019"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.M. Zain","raw_affiliation_strings":["Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037214066","display_name":"Lubomir Sokol","orcid":"https://orcid.org/0000-0003-0916-547X","observed_orcids":["https://orcid.org/0000-0003-0916-547X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Sokol","raw_affiliation_strings":["Dept of Hematological Malignancies, Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Hematological Malignancies, Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083104525","display_name":"Eric D. Jacobsen","orcid":"https://orcid.org/0000-0003-3014-0023","observed_orcids":["https://orcid.org/0000-0003-3014-0023"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Jacobsen","raw_affiliation_strings":["Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005718112","display_name":"Manish R. Patel","orcid":"https://orcid.org/0000-0001-6836-2364","observed_orcids":["https://orcid.org/0000-0001-6836-2364"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210118420","display_name":"Florida Cancer Specialists & Research Institute","ror":"https://ror.org/02px37122","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118420"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.R. Patel","raw_affiliation_strings":["Oncology, Sarah Cannon Research Institute (Nashville, TN); Florida Cancer Specialists & Research Institute, Sarasota, FL, USA","Florida Cancer Specialists & Research Institute, Sarasota, FL, USA","Oncology, Sarah Cannon Research Institute (Nashville, TN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Sarah Cannon Research Institute (Nashville, TN); Florida Cancer Specialists & Research Institute, Sarasota, FL, USA","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210118420"]},{"raw_affiliation_string":"Florida Cancer Specialists & Research Institute, Sarasota, FL, USA","institution_ids":["https://openalex.org/I4210118420"]},{"raw_affiliation_string":"Oncology, Sarah Cannon Research Institute (Nashville, TN)","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069406522","display_name":"Steven Michael Horwitz","orcid":"https://orcid.org/0000-0002-6399-2006","observed_orcids":["https://orcid.org/0000-0002-6399-2006"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.M. Horwitz","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Meric-Bernstam","raw_affiliation_strings":["Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059661907","display_name":"Andrei R. Shustov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Shustov","raw_affiliation_strings":["Division of Hematology, Seattle Cancer Care Alliance, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Seattle Cancer Care Alliance, Seattle, WA, USA","institution_ids":["https://openalex.org/I1332479046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Weinstock","raw_affiliation_strings":["Weinstock Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weinstock Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018540281","display_name":"Manuel A. Aivado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Aivado","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061797400","display_name":"D. Allen Annis","orcid":"https://orcid.org/0000-0002-3953-4590","observed_orcids":["https://orcid.org/0000-0002-3953-4590"]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.A. Annis","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.6066,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.70652675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"28","issue":null,"first_page":"v370","last_page":"v370"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.7163000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.7163000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.2386000007390976,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stapled-peptides","display_name":"stapled peptides","score":0.7540000081062317},{"id":"https://openalex.org/keywords/mdmx","display_name":"MDMX","score":0.6639999747276306},{"id":"https://openalex.org/keywords/mdm2","display_name":"MDM2","score":1.0},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.7870000004768372},{"id":"https://openalex.org/keywords/p53-inhibitors","display_name":"p53 inhibitors","score":0.6299999952316284},{"id":"https://openalex.org/keywords/peripheral-t-cell-lymphoma","display_name":"peripheral T-cell lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/angioimmunoblastic-t-cell-lymphoma","display_name":"angioimmunoblastic T-cell lymphoma","score":0.8949999809265137},{"id":"https://openalex.org/keywords/anaplastic-large-cell-lymphoma","display_name":"anaplastic large cell lymphoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/cell-penetrating-peptides","display_name":"cell-penetrating peptides","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8503153920173645},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6224173903465271},{"id":"https://openalex.org/C2777589544","wikidata":"https://www.wikidata.org/wiki/Q7667896","display_name":"T-cell lymphoma","level":3,"score":0.4578685760498047},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.4511250853538513},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4363471269607544},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4189453125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39654937386512756},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39210107922554016},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.34772658348083496},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28666865825653076},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2180798053741455}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdx373.045","doi":"https://doi.org/10.1093/annonc/mdx373.045","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx373.045","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)38311-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdx373.045","doi":"https://doi.org/10.1093/annonc/mdx373.045","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx373.045","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(20)38311-3/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2761941968.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2909583409","https://openalex.org/W2980668212","https://openalex.org/W2904735514","https://openalex.org/W3202548245","https://openalex.org/W3203969607","https://openalex.org/W2955390241","https://openalex.org/W3095747953","https://openalex.org/W4235576882","https://openalex.org/W2993835348","https://openalex.org/W2804974301"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2017-10-20T00:00:00"}